Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

More Damage Detected from Crispr-Cas9 Edits

Crispr genome edits illustration

A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood. . . . → Read More: More Damage Detected from Crispr-Cas9 Edits

New $315 Million Life Sciences Venture Fund Unveiled

Investment graphic

A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled

Pet Health Ingredients Shown Effective Against Mosquito-Borne Diseases

Baby with microcephaly

Researchers in the U.S. and the Netherlands found ingredients in over-the-counter products to control fleas and ticks in house pets can also help prevent infectious diseases in humans spread by mosquitoes. . . . → Read More: Pet Health Ingredients Shown Effective Against Mosquito-Borne Diseases

Inexpensive Blood Test Technique Devised for Hepatitis-B

Hepatitis-B screening

An international research team developed a simple blood testing process to diagnose hepatitis-B at a small fraction of the cost as current methods. . . . → Read More: Inexpensive Blood Test Technique Devised for Hepatitis-B

Robotics, A.I. Employed for Personal Autism Therapy

Nao robot

An engineering lab at MIT developed techniques for combining robotics with deep learning, a form of artificial intelligence, to personalize autism therapy. . . . → Read More: Robotics, A.I. Employed for Personal Autism Therapy

Cannabis Drug Approved by FDA for Rare, Severe Seizures

Cannabis plant

A drug based on chemicals derived from cannabis plants was approved by Food and Drug Administration for marketing in the U.S. to treat seizures associated with two rare and severe forms of epilepsy. . . . → Read More: Cannabis Drug Approved by FDA for Rare, Severe Seizures

Cancer T-Cell Start-Up Gains $150 Million in IPO

NASDAQ share price display

A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO

Electrodes for Implants 3-D Printed on Soft Materials

Electrodes on gummy bears

An engineering team produced with an ink-jet printer working electrodes like those used in medical implants on bio-friendly soft materials rather than metal or silicon. . . . → Read More: Electrodes for Implants 3-D Printed on Soft Materials

Gates Backs Engineered Mosquitoes to Stop Malaria

Anopheles mosquito

A company that applies genetic engineering to limit the spread of disease-carrying pests is partnering with the Bill and Melinda Gates Foundation to develop mosquitoes that stop the spread of malaria. . . . → Read More: Gates Backs Engineered Mosquitoes to Stop Malaria

UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Editing DNA

University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent